A liquid chromatographic method for vitamin K 1 in milk-based infant formula is described. The vitamins are extracted from infant formula by matrix solid-phase dispersion and quantitated by reversed-phase chromatography with fluorescence detection. Vitamin K 1 is converted to the fluorescent hydroquinone with a postcolumn zinc reductive reactor. The limit of detection is 12 pg, and the limit of quantitation is 38 pg on-column. Linear responses were obtained in the range 0.55-22.1 ng/mL (r 2 = 0.9998). Recoveries of vitamin K 1 from an analyte-fortified blank material for milk-based infant formula averaged 91.7% (n = 25). The method provides a rapid, specific, and easily controlled assay for vitamin K 1 in fortified infant formula. U nlike other fat-soluble vitamins, vitamin K 1 is unstable to alkaline conditions and cannot withstand saponification. For this reason, innovative extraction procedures have been developed to quantitate vitamin K in foods and other biological matrixes. Vitamin K 1 methods recently were reviewed in detail by Eitenmiller and Landen (1). Information on the vitamin K content of the food supply was greatly expanded through the work of Sadowski's research group at the U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University (2-12). Procedural aspects of the methodology were recently reviewed (13). Use of postcolumn chemical reduction of the quinone to the fluorescent hydroquinone allows selective and sensitive quantitation of vitamin K 1 after solid-phase extraction on silica and/or C 18 and reversed-phase chromatography.
U nlike other fat-soluble vitamins, vitamin K 1 is unstable to alkaline conditions and cannot withstand saponification. For this reason, innovative extraction procedures have been developed to quantitate vitamin K in foods and other biological matrixes. Vitamin K 1 methods recently were reviewed in detail by Eitenmiller and Landen (1) . Information on the vitamin K content of the food supply was greatly expanded through the work of Sadowski's research group at the U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Procedural aspects of the methodology were recently reviewed (13) . Use of postcolumn chemical reduction of the quinone to the fluorescent hydroquinone allows selective and sensitive quantitation of vitamin K 1 after solid-phase extraction on silica and/or C 18 and reversed-phase chromatography.
Development of reliable fluorescence-based detection systems for converting the quinone (vitamin K) to the fluorescent hydroquinone followed the original work of Lagenberg and coworkers (14) (15) (16) and Haroon et al. (17) , who used electrochemical and chemical reduction, respectively, to determine vitamin K 1 in plasma and other biological samples.
In the United States, infant formula is fortified at 4 µg vitamin K 1 per serving (18) . The current AOAC INTERNA-TIONAL method (Method 992.27) for vitamin K 1 in infant formula (19) is based on studies by Hwang (20) that involve pretreatment of the formula with ammonium hydroxide and methanol followed by extraction with dichloromethane-isooctane, 2 + 1. Open-column silica chromatography is required for cleanup of the extract prior to normal-phase liquid chromatography (LC) on silica. Advantages of the AOAC INTERNATIONAL method are the avoidance of saponification and the ability to resolve vitamin K 1 from the biologically inactive cis isomer present in synthetic vitamin K 1 preparations. Problems with the AOAC method include hard-to-interpret chromatograms due to lipid interferences, inability to measure cis-vitamin K 1 in matrixes containing corn oil, and an overall high repeatability relative standard deviation (RSD r ) of 20.9% (1) .
Because of these deficiencies, investigators have explored many analytical avenues to improve methods for analysis of vitamin K 1 in infant formula. Indyk et al. (21) assayed total vitamin K 1 (trans and cis isomers) in infant formula by incorporating lipase digestion (22) , extraction of the digest with hexane after addition of ethanol-methanol (95 + 5) and potassium carbonate, and semipreparative LC fractionation on silica. The purified extract was quantitated for vitamin K 1 content by reversed-phase chromatography on C 18 with detection at 269 nm. Because of the inability of reversed-phase chromatography to resolve trans-and cis-vitamin K 1 , the method provided a measure of total vitamin K 1 . However, the authors commented that the procedure was acceptable for production compliance because samples are monitored with reference to total vitamin K 1 .
In more recent work, Indyk and Woollard (23) provided a simplified approach to the analysis of total vitamin K 1 in milk and infant formula. The method involves lipase digestion, extraction of the digest as previously noted (21), and centrifugation. Semipreparative LC was eliminated, and the hexane extract was evaporated with the residue redissolved in methanol. LC analysis incorporated postcolumn zinc reduction to induce formation of fluorescence and reversed-phase LC for quantitation of total vitamin K 1 . Recently, the method was subjected to an AOAC INTERNATIONAL collaborative study.
Ware et al. (24) used lipase and α-amylase digestion, extraction with 1% sodium bicarbonate-isopropyl alcohol (1 + 1), and C 18 solid-phase cleanup to prepare a variety of medical foods for vitamin K 1 analysis. Their determinative step used zinc reduction (postcolumn) and reversed-phase LC to measure total vitamin K 1 . The method was applicable to a wide selection of medical foods of varying protein and fat contents. Zinc postcolumn reduction was used by Jakob and Elmadfa (25) in a study of the vitamin K 1 content of animal and plant foods. Electrochemical detection efficiently was used by Piironen et al. (26) and Koivu et al. (27) in determining vitamin K 1 in oils, margarine, butter, and cereals, respectively. The method relied on semipreparative LC for cleanup of extracts and use of MK-4 as an internal standard.
Researchers at the Atlanta Center for Nutrient Analysis, of the U.S. Food and Drug Administration, recently have established matrix solid-phase dispersion (MSPD) as a rapid and simple technique to extract retinyl palmitate, all-rac-α-tocopheryl acetate, vitamin E, and β-carotene from infant formula and medical foods (28) (29) (30) (31) . MSPD is a nonaggressive extraction approach that not only saves time and solvents but also decreases the chance for manual errors and analyte degradation. The objective of this research was to use MSPD to extract vitamin K 1 from infant formula and couple the analysis to zinc postcolumn reduction to utilize fluorescence as the detection mode. 
Sample Description and Preparation
A zero control reference material (ZRM; 32) originally used for fat-soluble method development studies was used for recovery studies. National Institute of Standards and Technology (NIST; Gaithersburg, MD) SRM 1846, milk-based infant formula, also was used to validate the method. The infant formula ZRM was prepared by weighing ca 10 g of the ZRM, combining it with 50 g boiling water, and thoroughly mixing. For SRM 1846, the entire packet contents (ca 30 g) was weighed, combined with 150 g water (90°-100°C), and thoroughly mixed.
Sample Extraction
Weigh 2 g Bondesil C 18 into a mortar. Add 100 µL isopropyl palmitate and gently blend the isopropyl palmitate onto the C 18 with a pestle. Accurately weigh 0.50 g reconstituted sample into the C 18 -isopropyl palmitate mixture and add the spike solution. Use the pestle to gently blend the reconsituted sample and the C 18 -isopropyl palmitate into a fluffy, slightly sticky powder. Accurately transfer the C 18 -matrix blend into a 15 mL reservoir tube with a frit at the bottom and then insert the top frit on the powdery mix. Tightly compress the reservoir contents with a 10 cc syringe plunger. Pass 9 mL 0.5% isopropyl alcohol in hexane followed by 9 mL ethyl acetate through the reservoir. Collect both eluates into a 50 mL Turbo Vap vessel. Evaporate the combined eluates at 45°C in the Turbo Vap under 5 psi of nitrogen to near dryness. Dilute residue to 1 mL with hexane. Agitate the Turbo Vap vessel on a Vortex mixer for 15 s and then sonicate 
Calculation
The concentrations (ng/mL) of vitamin K 1 in the sample extract are calculated by linear regression analysis. Figure 1A shows a chromatogram of naturally occurring vitamin K 1 in the blank. Vitamin K 1 is native to many oils used in infant formula and is present at a level (100 ng/g) corresponding to less than 2 µg/100 kcal of infant formula, which is less than half the minimum level of 4 µg/100 kcal required by law (18) . Because by definition a ZRM is devoid of the nutrient of interest (32) , this low level found for vitamin K 1 makes the ZRM suitable for use as a blank for spiking purposes, provided that each spiking level is corrected for the natural occurring vitamin K 1 . Figure 1B shows the chromatogram of a vitamin K 1 standard overlaid with the extract of a commercial infant formula at a concentration of 277 pg on-column. Fluorescence responses for vitamin K 1 hydroquinone were linear from 0.55 to 22.1 ng vitamin K 1 /mL (r 2 = 0.9998). A standard set consisting of 5 standards in the concentration range 0.55-22.1 ng/mL injected in duplicate on 9 occasions over a 26-day period gave a standard deviation of ± 732 (coefficient of variation, CV = 5.9%). The vitamin K 1 hydroquinone gave a limit of detection of 0.20 ng vitamin K 1 /mL, corresponding to about 27 ng/g, or an on-column concentration equivalent to 12 pg. The limit of quantitation was 0.64 ng vitamin K 1 /mL, corresponding to 80 ng/g or an on-column concentration equivalent to 38 pg. Table 1 shows recoveries from milk-based infant formula blanks spiked at the 1/2×, ×, 2×, 4×, and 8× levels, where × is the minimum level for vitamin K 1 as listed in the Code of Federal Regulations (18) . Each spiking level was assayed 5 times. The 100 ng/g level found in 5 replicates of the blank served as a baseline value and was subtracted from each subsequent spiking level.
Results and Discussion
Vitamin K 1 recoveries were acceptable over the spiking range studied, given that spiking levels are in the parts-per-billion range. Our laboratory has observed that most infant formulas are fortified at either 8 or 15 µg vitamin K 1 /100 kcal. Usually, even with an overage of fortification, the method is more than adequate to assay vitamin K 1 at levels of 150% of label declaration.
Additionally, the method was tested on 10 replicates of NIST milk-based infant formula SRM 1846. For this study, the entire packet of SRM 1846 was mixed with 150 mL water (90°-100°C). Total vitamin K 1 in SRM 1846 was 0.944 ± 0.026 mg/kg (CV = 2.8%). This amount agrees with the NIST certificate for SRM 1846, which lists vitamin K 1 as a mass fraction of 1 mg/kg but does not provide a certified value for vitamin K 1 . Our laboratory routinely assays SRM 1846 by the AOAC INTERNATIONAL method (1) that study, as well as in our regulatory laboratory, 2.5 g from each packet of SRM 1846 was dissolved in hot water (50°-60°C). According to the new certificate released by NIST, the SRM 1846 sample is to be mixed with water at 90°-100°C to avoid problems with homogeneity.
Analysis of an in-house control consisting of a commercially available milk-based infant formula gave 11.4 ± 0.57 µg/100 kcal (CV = 4.9%; n = 10). This value corresponds to 143% of the label declaration and is consistent with the values that are routinely observed in our laboratory with the AOAC method (19) and with the expected overages used in fortification.
As an integral part of any method development work, the peak purity of the vitamin K 1 was established by peak ratios (17) . The emission wavelength was kept constant for analytes while fluorescence was measured at 3 excitation wavelengths. The fluorescence emission of vitamin K 1 at 418 nm was determined at excitation wavelengths of 238, 248, and 258 nm. Ratios were calculated for 238/248 and 258/248 and compared for the standard and the commercial infant formula extract (Table 2 ). Good agreement was obtained for ratios of standard and sample for vitamin K 1 , indicating purity of the vitamin K 1 peaks.
Addition of hexane to the mobile phase, standards, and samples is essential to maintain low column backpressure and good recoveries. When hexane was not used, column pressure became excessive from fat buildup on the column. Use of 10% hexane, which is miscible with methanol, kept the fat in solution and allowed maintenance of a lower column pressure. Hexane also increased recoveries by solubilizing vitamin K 1 , which is only sparingly soluble in methanol.
Previously, Chase et al. (28) (29) (30) (31) used isopropyl palmitate as a modifier for the efficient elution of retinyl palmitate. But because retinyl palmitate was not quantitated in that study, we tried to eliminate it from the method. Initial studies without the retinyl palmitate resulted in recoveries as low as 70%. As discussed in an earlier work (28) , the isopropyl palmitate acts as a keeper solvent for the vitamin K 1 . Figure 2 represents 90 injections of the extract of the in-house control. Because MSPD does not remove the fat, we determined whether the fat would have an effect on the zinc reduction column. Initially, 10 injections were made of the extract of the in-house control to serve as a baseline from which to measure the change for the remaining 90 injections. When the hexane was omitted from the mobile phase, the response for the vitamin K 1 in the in-house control extract changed by >20% after 90 injections. However, inclusion of hexane in the mobile phase, standards, and sample extracts resulted in a change of <10% for 90 injections. The peak response and retention time of the standard injected after every 20 sample injections remained unchanged. No problems were observed with miscibility with 10% hexane in methanol.
This method provides a simple and rapid technique to assay vitamin K 1 in milk-based infant formula and requires only 18 mL solvent per sample. The small sample size of 0.5 g is not detrimental because properly prepared liquid samples are homogenous and the small sample size does not significantly influence the data. A competent analyst can easily extract 20 samples in 1 working day with overnight injections.
